Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Eli Lilly and Company Expands Carolina, Puerto Rico, Manufacturing Operations

11/12/2025
Global pharmaceutical company Eli Lilly and Company will expand and modernize its operations in Carolina, Puerto Rico. The $1.2 billion project is expected to create 100 jobs.

The investment will integrate advanced technologies and expand production capacity at the company’s existing manufacturing site to support its growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology.

"After sixty years, Lilly del Caribe continues to play an important role in making life-changing medicines for people in the U.S. and beyond," said Edgardo Hernandez, executive vice president and president of Lilly Manufacturing Operations. "Our continued investments in capacity, infrastructure, advanced technologies and highly specialized jobs will further cement the site's significance in Lilly's global manufacturing network. Our progress builds on the dedication and expertise of our local team, helping us deliver new medicines for patients around the world."

"This historic investment stands as proof of what can be achieved when the private sector and government work hand in hand toward a shared vision of competitiveness and economic growth," noted Sebastian Negron Reichard, Secretary of the Department of Economic Development and Commerce, Puerto Rico. "For over sixty years, Lilly has trusted Puerto Rico, its people, its talent and its potential. Today, that trust translates into new capacity, advanced technologies, investment and long-term economic value for our island. This is exactly the kind of partnership that defines our economic development strategy and strengthens Puerto Rico's position as a global leader in life sciences manufacturing."

Exclusive Research